- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04182971
Effect of Added Fruit Pomace Fiber, Juice, and Whole Fruit on Postprandial Glycemia
December 3, 2019 updated by: PepsiCo Global R&D
Compare the effects of whole orange, orange juice alone, and orange juice with added orange pomace fiber, and whole apple, apple juice alone, and apple juice with added apple pomace fiber, on 2h glycemic response.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
58
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60661
- IIT (Illinois Institute of Technology), Center for Nutrition Research, Institute for Food Safety and Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- BMI 20-24.9 kg/m2 and weight >=110 lbs at screening
- Willing to maintain usual physical activity pattern and exercise level
- Willing to follow instructions for compliance with dietary restrictions, dosing and visits
- In good health based on medical history
- Willing to avoid alcohol for 24 hrs prior to visits
- Willing to maintain stable dose of vitamins, minerals, supplements, and medications not interfering with study outcomes including birth control for the study
- Understands procedures, signs informed consent and authorization for release of relevant protected health information and is willing to complete study procedures
Exclusion Criteria:
- Fasting finger stick glucose >100
- Uncontrolled hypertension
- Major trauma or surgical event within 2 months of Visit 1
- Weight change > 4.5 kg within 2 months, taking weight loss drugs, bariatric surgery, or other weight reduction surgery (liposuction, laser fat removal, etc.)
- History or presence of clinically important endocrine, cardiovascular, pulmonary, bilary or gastrointestinal disorders that could interfere with the interpretation of study results
- History or presence of cancer in past 2 yrs except for non-melanoma skin cancer
- History of extreme dietary habits (Atkins, etc.)
- History of eating disorder
- Known intolerance or sensitivity to any of the ingredients in the study products
- Subject has used medications know to influence carbohydrate metaboism 2 weeks prior to visit and throughout the study
- Subject is taking systemic steroids, extreme alcohol use or drug user
- Vein access score < 7
- Pregnant, planning to become pregnant, or lactating
- Current smoker or smoked within past 2 yrs
- Has not participated in another clinical trial for past 30 days or another PepsiCo study in past 6 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Whole fruit
Phase 1 of study is an orange, Phase 2 of study is an apple
|
Phase 1 is 227g of orange fruit, Phase 2 is 230g of apple fruit
|
Active Comparator: Juice
Phase 1 of study is orange juice, Phase 2 of study is apple juice
|
Phase 1 is 250g of orange juice, Phase 2 is 235g of apple juice
|
Experimental: Juice plus pomace fiber
Phase 1 is orange juice with added fiber, Phase 2 is apple juice with added fiber
|
Phase 1 is 157g of orange juice + 100g of orange pomace fiber (39% pomace by weight), Phase 2 is 129g of apple juice + 106g of apple pomace fiber (45% pomace by weight)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glucose
Time Frame: 0-120 minutes
|
Cmax, plasma
|
0-120 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Glucose
Time Frame: 0-120 minutes
|
iAUC, plasma
|
0-120 minutes
|
Insulin
Time Frame: 0-120 minutes
|
iAUC, plasma
|
0-120 minutes
|
Glucose
Time Frame: 0-120 minutes
|
Tmax, plasma
|
0-120 minutes
|
Insulin
Time Frame: 0-120 minutes
|
Cmax, plasma
|
0-120 minutes
|
Insulin
Time Frame: 0-120 minutes
|
Tmax, plasma
|
0-120 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 28, 2018
Primary Completion (Actual)
September 3, 2019
Study Completion (Actual)
September 3, 2019
Study Registration Dates
First Submitted
November 27, 2019
First Submitted That Met QC Criteria
November 27, 2019
First Posted (Actual)
December 2, 2019
Study Record Updates
Last Update Posted (Actual)
December 5, 2019
Last Update Submitted That Met QC Criteria
December 3, 2019
Last Verified
December 1, 2019
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
IPD Plan Description
After publication, investigator can be contacted to discuss requests.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glycemic Index
-
Mondelēz International, Inc.Reading Scientific Services Ltd.Completed
-
Aga Khan UniversityUnknown
-
Danone Asia Pacific Holdings Pte, Ltd.Completed
-
Arizona State UniversityStandard Process Inc.Terminated
-
Azienda Ospedaliera Specializzata in Gastroenterologia...Unknown
-
Nutrition Institute, SloveniaSlovenian Research Agency; Valens Int. d.o.o., Slovenija; Community Health Centre...CompletedGlycemic IndexSlovenia
-
Azienda di Servizi alla Persona di PaviaRecruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityCompleted
-
Nutrition Institute, SloveniaValens Int. d.o.o., SlovenijaCompleted
Clinical Trials on Fruit
-
Ocean Spray Cranberries, Inc.Recruiting
-
University of California, San FranciscoMount Zion Health Fund; Miracle Fruit FarmRecruitingHead and Neck Cancer | Taste DysfunctionUnited States
-
Unilever R&DCompleted
-
Wholesome WaveYale-Griffin Prevention Research Center; One Community HealthCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus | PovertyUnited States
-
KU LeuvenMildmay Uganda LimitedCompletedHypertension | Dyslipidemias | Cardiometabolic SyndromeUganda
-
King's College LondonLucozade Ribena SuntoryCompletedHealthy Men and WomenUnited Kingdom
-
King's College LondonLucozade Ribena SuntoryCompletedHealthy Men and WomenUnited Kingdom
-
San Diego State UniversityActive, not recruitingHealthy Aging | Cognition | Cardiometabolic HealthUnited States
-
King's College LondonImperial College London; Queen Mary University of LondonRecruitingConstipation - FunctionalUnited Kingdom
-
Universidade Nova de LisboaCompleted